Reirradiation for Sinonasal Adenoid Cystic Carcinoma in a Low-Middle Income Setting: A Case Report and Literature Review
Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radio...
Saved in:
| Published in: | Case reports in oncology Vol. 18; no. 1; pp. 1 - 11 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
01.01.2025
|
| Subjects: | |
| ISSN: | 1662-6575, 1662-6575 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric modulated arc therapy (VMAT) as a feasible reirradiation option in such settings. Case presentation: We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk. The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up nor distant metastasis. Conclusions: This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors where therapeutic options are limited. |
|---|---|
| AbstractList | Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings.
We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis.
This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited. Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings.IntroductionReirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings.We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis.Case PresentationWe report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis.This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited.ConclusionsThis case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited. Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric modulated arc therapy (VMAT) as a feasible reirradiation option in such settings. Case presentation: We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk. The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up nor distant metastasis. Conclusions: This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors where therapeutic options are limited. |
| Author | Zarraa, Semia Attia, Najla Naija, Bouchra Kaabia, Wael Nasr, Chiraz Ben Zid, Khadija Ghorbel, Asma Abidi, Rim Mousli, Alia |
| Author_xml | – sequence: 1 givenname: Wael orcidid: 0009-0006-1553-8649 surname: Kaabia fullname: Kaabia, Wael – sequence: 2 givenname: Alia surname: Mousli fullname: Mousli, Alia – sequence: 3 givenname: Najla surname: Attia fullname: Attia, Najla – sequence: 4 givenname: Bouchra surname: Naija fullname: Naija, Bouchra – sequence: 5 givenname: Asma surname: Ghorbel fullname: Ghorbel, Asma – sequence: 6 givenname: Khadija surname: Ben Zid fullname: Ben Zid, Khadija – sequence: 7 givenname: Semia surname: Zarraa fullname: Zarraa, Semia – sequence: 8 givenname: Rim surname: Abidi fullname: Abidi, Rim – sequence: 9 givenname: Chiraz surname: Nasr fullname: Nasr, Chiraz |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/41063869$$D View this record in MEDLINE/PubMed |
| BookMark | eNpN0U1PwzAMBuAIDbEPOPAHUI5wKCRNk67cpoqPSUNIG5yrtHFRUJuMJGXs39NpY-Jky37kw-sxGhhrAKFLSm4p5dkdIYQnacLiEzSiQsSR4Ckf_OuHaOz9JyEi44KfoWFCiWBTkY3QzxK0c1JpGbQ1uLYOr3R_XnrZ4JkCY7XC-dYHXeFcuqrftRJrgyVe2E30opVqAM9NZVvAKwhBm497POutB7yEtXUBS6PwQgdwMnRuN_3WsDlHp7VsPFwc6gS9Pz685c_R4vVpns8WURVP4xAlVDEuCaOiSgjNSh7LDLIYaigpq1NBaMqVYLRPgEFNSiYYSCIZqVXKesYm6Hp_d-3sVwc-FK32FTSNNGA7X7CYZyQjCaM9vTrQrmxBFWunW-m2xV9aPbjZg8pZ7x3UR0JJsftEcfwE-wUK2XjG |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s). Published by S. Karger AG, Basel. |
| Copyright_xml | – notice: 2025 The Author(s). Published by S. Karger AG, Basel. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1159/000547432 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1662-6575 |
| EndPage | 11 |
| ExternalDocumentID | 41063869 10_1159_000547432 |
| Genre | Journal Article Case Reports |
| GroupedDBID | --- 0~B 29B 3O. 53G 5GY 5VS 6J9 7X7 8FI 8FJ AAYXX ABBTS ABDBF ABPAZ ABUWG ABWCG ACGFS ACUHS ADBBV AEGXH AEYAO AFKRA AHFRZ AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL BCNDV BENPR BPHCQ BVXVI CAG CCPQU CITATION DIK E0A E3Z EBS F5P FB. FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR ITC KQ8 M-- M~E O5R O5S OK1 PHGZM PQQKQ PROAC RNS RPM TR2 UKHRP 4.4 ADRAZ C1A COF CYUIP EJD IPNFZ M48 NPM RIG 7X8 |
| ID | FETCH-LOGICAL-c282t-41d35a0316c4019b52a9e92efeb13f760175d6310053ef0b363ea0a30fd732ef3 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001563008000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1662-6575 |
| IngestDate | Thu Oct 09 19:01:07 EDT 2025 Sun Oct 12 01:41:05 EDT 2025 Sat Nov 29 07:43:01 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Reirradiation Volumetric-modulated arc therapy Tumor recurrence Low-middle income setting Head and neck cancer Radiotherapy Adenoid cystic carcinoma Ethmoidal sinus |
| Language | English |
| License | https://creativecommons.org/licenses/by-nc/4.0 2025 The Author(s). Published by S. Karger AG, Basel. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c282t-41d35a0316c4019b52a9e92efeb13f760175d6310053ef0b363ea0a30fd732ef3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0009-0006-1553-8649 |
| OpenAccessLink | https://karger.com/cro/article-pdf/doi/10.1159/000547432/4406790/000547432.pdf |
| PMID | 41063869 |
| PQID | 3259090431 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_3259090431 pubmed_primary_41063869 crossref_primary_10_1159_000547432 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-01 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Case reports in oncology |
| PublicationTitleAlternate | Case Rep Oncol |
| PublicationYear | 2025 |
| SSID | ssj0069565 |
| Score | 2.3063145 |
| Snippet | Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and... Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 1 |
| Title | Reirradiation for Sinonasal Adenoid Cystic Carcinoma in a Low-Middle Income Setting: A Case Report and Literature Review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/41063869 https://www.proquest.com/docview/3259090431 |
| Volume | 18 |
| WOSCitedRecordID | wos001563008000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1662-6575 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069565 issn: 1662-6575 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1662-6575 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069565 issn: 1662-6575 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVKGR databaseName: Karger Open Access Journals customDbUrl: eissn: 1662-6575 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069565 issn: 1662-6575 databaseCode: M-- dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.karger.com/OpenAccess providerName: Karger AG – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1662-6575 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069565 issn: 1662-6575 databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1662-6575 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069565 issn: 1662-6575 databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe6DSEuiG_KR2UQ4jJFpEls19zC1AmJNEyjg94iJ3FEpi4pSTvKhSN_N89x4rYaSOPAxarc1LH8fn1-Hz8_I_QKTApG7ZRZmZ1wy6PEseIsTeEfz4mXUZF4zan3zwELw9Fsxk96vV_dWZjLOSuK0XrNF_9V1NAHwlZHZ_9B3GZQ6IDPIHRoQezQXkvwpzKvKlVxwLAIP-Xg44taCQO0TJmnh0c_VHlmxfZI4LsLoaIe4jAov1uTJmCh1EZ5IUGTLLsT0T48XcvWYG9SDoGpyLydYTBVD2ppEhIwelkkOwH8D0LEmqf7pWPtN9TfVa3Pa_vz3GwYPkxC6K3gfG56Q5Gf63ujy1XytRLb8QuHbMUvtMql1FEEHJ3bln_ou6KnOzxeVf-Ea74k8cAycjZ7XJfXDz9Gx2dBEE3Hs-nrxTdL3T6msvTtVSx76MBhhCtq4OTnuNvRKfiQigprZtVWqIK3vTHv2rVr_uKsNEbL9A663Xob2NcouYt6sriHbk5aPsV9tN4BCwawYAMW3IIFa7BgAxacF1jgDViwBgtuwfIW-1hJH2uoYIAK3kAFa6g8QGfH4-nRe6u9i8NKwClfWt4wdYmAHYAm4JHzmDiCS-7IDPZ6N1PEKkZSqrJFxJWZHbvUlcIWrp2lzIXH3IdoH6YvHyOsqcssFkx4KpQt5NBxUpGkNne8jMV99LJbyWihS65EjatKeGSWu49edGscgUJUWS5RSABp5IJDb3NVM6qPHunFN8N4Q2WhU_7kGr9-im5t4PoM7S-rlXyObiSXy7yuBmiPzVjTjgbo4N04PDkdNPGcQQOd3zSBjrA |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reirradiation+for+Sinonasal+Adenoid+Cystic+Carcinoma+in+a+Low-Middle+Income+Setting%3A+A+Case+Report+and+Literature+Review&rft.jtitle=Case+reports+in+oncology&rft.au=Kaabia%2C+Wael&rft.au=Mousli%2C+Alia&rft.au=Attia%2C+Najla&rft.au=Naija%2C+Bouchra&rft.date=2025-01-01&rft.issn=1662-6575&rft.eissn=1662-6575&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1159%2F000547432&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-6575&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-6575&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-6575&client=summon |